Arrowhead Pharmaceuticals (ARWR) Return on Equity: 2011-2025
Historic Return on Equity for Arrowhead Pharmaceuticals (ARWR) over the last 14 years, with Sep 2025 value amounting to 0.06%.
- Arrowhead Pharmaceuticals' Return on Equity rose 236.00% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 236.00%. This contributed to the annual value of 0.09% for FY2025, which is 264.00% up from last year.
- According to the latest figures from Q3 2025, Arrowhead Pharmaceuticals' Return on Equity is 0.06%, which was up 122.19% from -0.26% recorded in Q2 2025.
- In the past 5 years, Arrowhead Pharmaceuticals' Return on Equity registered a high of 0.06% during Q3 2025, and its lowest value of -5.26% during Q4 2024.
- Its 3-year average for Return on Equity is -1.24%, with a median of -0.63% in 2023.
- As far as peak fluctuations go, Arrowhead Pharmaceuticals' Return on Equity slumped by 394bps in 2024, and later skyrocketed by 236bps in 2025.
- Over the past 5 years, Arrowhead Pharmaceuticals' Return on Equity (Quarterly) stood at -0.47% in 2021, then increased by 9bps to -0.38% in 2022, then crashed by 93bps to -1.31% in 2023, then plummeted by 394bps to -5.26% in 2024, then soared by 236bps to 0.06% in 2025.
- Its last three reported values are 0.06% in Q3 2025, -0.26% for Q2 2025, and -0.42% during Q1 2025.